Screener
Kforce KFRC Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $349.33M+4.5% | $330.36M+0.1% | $332.02M-3.4% | $332.65M-5.9% | $334.32M-6.2% | ||
| $249.88M+2.5% | $240.3M-0.6% | $241.81M-3.7% | $240.39M-5.6% | $243.67M-5.3% | ||
| $99.45M+9.7% | $90.07M+2.0% | $90.21M-2.6% | $92.26M-6.4% | $90.65M-8.4% | ||
| 28.5%+1.4pp | 27.3%+0.5pp | 27.2%+0.2pp | 27.7%-0.2pp | 27.1%-0.7pp | ||
| $79.41M+6.8% | $76.76M+2.1% | $80.33M+6.3% | $75.88M-3.1% | $74.37M-4.3% | ||
| $18.75M+26.0% | $12.01M+3.2% | $8.56M-45.1% | $15M-19.8% | $14.89M-24.4% | ||
| 5.4%+0.9pp | 3.6%+0.1pp | 2.6%-2.0pp | 4.5%-0.8pp | 4.5%-1.1pp | ||
| -$991K+3.7% | -$652K-15.4% | -$780K-53.5% | -$758K-76.7% | -$1.03M-104% | ||
| $17.76M+28.2% | $11.35M+2.6% | $7.78M-48.4% | $14.24M-22.1% | $13.86M-27.8% | ||
| $5.44M+59.5% | $3.43M+17.4% | $2.61M-34.8% | $3.18M-22.1% | $3.41M-32.3% | ||
| $12.32M+17.9% | $7.93M-2.7% | $5.16M-53.3% | $11.07M-22.1% | $10.45M-26.2% | ||
| 3.5%+0.4pp | 2.4%-0.1pp | 1.6%-1.7pp | 3.3%-0.7pp | 3.1%-0.8pp | ||
| $0.73+23.7% | $0.46+2.2% | $0.30-50.0% | $0.63-16.0% | $0.59-21.3% | ||
| $20.05M+23.2% | $13.31M+1.6% | $9.88M-42.1% | $16.37M-19.2% | $16.28M-23.4% | ||
| 5.7%+0.9pp | 4%+0.1pp | 3%-2.0pp | 4.9%-0.8pp | 4.9%-1.1pp | ||
| $18.75M+26.0% | $12.01M+3.2% | $8.56M-45.1% | $15M-19.8% | $14.89M-24.4% |
FAQ
- What is Kforce's revenue?
- Kforce (KFRC) generated $1.3B in revenue over the trailing twelve months, down 1.3% year over year.
- Is Kforce profitable?
- Kforce reported $36.5M in net income over the trailing twelve months, a 2.7% net margin.
- What are Kforce's profit margins?
- Gross margin is 27.7% and operating margin is 4.0%, with a 2.7% net margin.
- What is Kforce's earnings per share?
- Kforce's diluted EPS over the trailing twelve months is $2.12.
- Where does Kforce's income statement data come from?
- Every line is extracted from Kforce's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
